Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
HPV-positive OPSCC
combined modality therapy
double immune checkpoint inhibition
head and neck neoplasms
immunotherapy
induction therapy
organ preservation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
19 Apr 2021
19 Apr 2021
Historique:
received:
31
01
2021
revised:
20
03
2021
accepted:
14
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
To determine whether a single dose of double immune checkpoint blockade (induction chemoimmunotherapy (ICIT)) adds benefit to induction single-cycle platinum doublet (induction chemotherapy (IC)) in locally advanced head and neck squamous cell carcinoma (HNSCC), patients treated with cisplatin 30 mg/m
Identifiants
pubmed: 33921668
pii: cancers13081959
doi: 10.3390/cancers13081959
pmc: PMC8073509
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Natl Cancer Inst. 2009 Apr 1;101(7):498-506
pubmed: 19318632
N Engl J Med. 2007 Oct 25;357(17):1695-704
pubmed: 17960012
Ann Oncol. 2017 Sep 1;28(9):2206-2212
pubmed: 28911070
J Clin Oncol. 2016 Dec;34(34):4132-4141
pubmed: 27863190
Clin Cancer Res. 2020 Jul 1;26(13):3211-3219
pubmed: 32269052
Oral Oncol. 2018 Jun;81:45-51
pubmed: 29884413
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
JAMA Oncol. 2019 Feb 1;5(2):195-203
pubmed: 30383184
J Immunother Cancer. 2020 Oct;8(2):
pubmed: 33023982
Eur J Cancer. 2019 Jan;107:142-152
pubmed: 30576970
N Engl J Med. 2016 Nov 10;375(19):1856-1867
pubmed: 27718784
J Clin Oncol. 2017 Feb 10;35(5):490-497
pubmed: 28029303
Lancet Oncol. 2013 Mar;14(3):257-64
pubmed: 23414589
J Clin Oncol. 2006 Feb 1;24(4):593-8
pubmed: 16380415
Cell. 2017 Sep 7;170(6):1120-1133.e17
pubmed: 28803728
Curr Oncol Rep. 2020 Jun 29;22(8):81
pubmed: 32602047
N Engl J Med. 2007 Oct 25;357(17):1705-15
pubmed: 17960013
Ann Oncol. 2012 Oct;23(10):2708-2714
pubmed: 22492697
Ann Oncol. 2020 Jul;31(7):942-950
pubmed: 32294530
J Clin Oncol. 2018 Nov 1;36(31):3077-3083
pubmed: 30016178
Strahlenther Onkol. 2020 Jun;196(6):522-529
pubmed: 32006068
N Engl J Med. 2003 Nov 27;349(22):2091-8
pubmed: 14645636
Eur Arch Otorhinolaryngol. 2020 Jan;277(1):245-254
pubmed: 31583430
J Clin Oncol. 2008 Jul 1;26(19):3138-46
pubmed: 18474879
Lancet. 2019 Nov 23;394(10212):1915-1928
pubmed: 31679945
J Clin Oncol. 2005 Dec 1;23(34):8636-45
pubmed: 16275937
Strahlenther Onkol. 2014 Feb;190(2):192-8
pubmed: 24362503
J Exp Clin Cancer Res. 2019 Jun 13;38(1):255
pubmed: 31196207
Strahlenther Onkol. 2011 Jan;187(1):15-22
pubmed: 21234526
Methods Enzymol. 2020;632:389-415
pubmed: 32000906
Ann Oncol. 2017 Aug 1;28(8):1917-1922
pubmed: 28498880